Generic etoricoxib 120 mg film-
Sponsors
International Bio Service Co., Ltd., International Bio Service Co. Ltd., International Bio Service Co.,Ltd
Conditions
Bioequivalence Study,Bioequivalence study,For bioequivalence studied by compare the rate and extent of absorption of test formulation and reference formulation,
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA, Frosst Iberica, S.A., Spain) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180124005
Start: 2018-03-02Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180424001
Start: 2018-06-25Updated: 2026-03-30
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Etoricoxib Tablets 120 mg and Reference Product (ARCOXIA 120 mg) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20180925005
Start: 2018-12-16Target: 28Updated: 2026-03-30
Unknown Phase
A single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20181024004
Start: 2018-10-10Updated: 2026-03-30
A single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Etoricoxib 120 mg Film-coated Tablets and Reference Product (ARCOXIA) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20181024004
Start: 2018-10-10Updated: 2026-03-30